Q: Your lab develops experimental trial designs and data analysis methods for increasing the usefulness of mobile health interventions. Can you please give examples how these trials are being used in the areas of substance abuse, physical activity, or helping people quit smoking?...
Q: Your reputation for passion about engaging and empowering people precedes you. Can you please describe your role at the All of Us Research Program?...
“Every individual holds a valuable piece of the puzzle to understand disease and health, and researchers are all in need of more data. Discovery is hindered by putting the majority of data into small silos. Breaking down data silos and bringing individuals together will more...
Q: In a sentence, what is Luna DNA going to do?...
It’s been an announcement-packed JPMorgan Healthcare Conference in San Francisco this week!...
Genomics-based testing or new immunotherapies that revolutionize cancer care are changing how we approach disease...
Q: As a pioneer in high performance architectures for genomic research what are the biggest challenges that you see clients dealing with as they invest in precision medicine initiatives? ...
Q: Immunotherapy is considered a huge game-changer and holds a lot of promises. Is the hype around immunotherapy justified? What are some of the exciting developments in the recent years?...
Q: What are the benefits of the Precision BioSciences’ ARCUS genome editing platform and what makes it unique?...
Q: Olink has been rapidly growing its’ library of human protein biomarker assays. What are the popular clinical applications for your biomarker panels?...
